HIGH-DOSE INTRAVITREAL TOPOTECAN (100 µ G/0.1 CC) AS MONOTHERAPY FOR RECURRENT/REFRACTORY INTRAOCULAR RETINOBLASTOMA IN SEVEN EYES.

چکیده

To report the outcomes and safety of 100 μ g/0.1 cc intravitreal topotecan (IVitT100) as monotherapy for refractory/recurrent intraocular retinoblastoma. Retrospective single-center study of 7 patients with retinoblastoma who received IVitT100 as monotherapy between January 2024 and December 2024…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط

• لنز داخل چشمی